Literature DB >> 15062084

Solution structure of ZASP PDZ domain; implications for sarcomere ultrastructure and enigma family redundancy.

Yunghan Au1, R Andrew Atkinson, Remo Guerrini, Geoff Kelly, Catherine Joseph, Steven R Martin, Frederick W Muskett, Alberto Pallavicini, Georgine Faulkner, Annalisa Pastore.   

Abstract

Z band alternately spliced PDZ-containing protein (ZASP) is a sarcomere Z disk protein expressed in human cardiac and skeletal muscle that is thought to be involved in a dominant familial dilated cardiomyopathy. The N-terminal PDZ domain of ZASP interacts with the C terminus of alpha-actinin-2, the major component of the Z disk, probably by forming a ternary complex with titin Z repeats. We have determined the structure of ZASP PDZ by NMR and showed that it is a classical class 1 PDZ domain that recognizes the carboxy-terminal sequence of an alpha-actinin-2 calmodulin-like domain with micromolar affinity. We also characterized the role of each component in the ternary complex ZASP/alpha-actinin-2/titin, showing that the alpha-actinin-2/ZASP PDZ interaction involves a binding surface distinct from that recognized by the titin Z repeats. ZASP PDZ structure was used to model other members of the enigma family by homology and to predict their abilities to bind alpha-actinin-2.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15062084     DOI: 10.1016/j.str.2004.02.019

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  21 in total

1.  Actin cytoskeleton remodeling by the alternatively spliced isoform of PDLIM4/RIL protein.

Authors:  Olga A Guryanova; Judith A Drazba; Elena I Frolova; Peter M Chumakov
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

2.  Functional dynamics of PDZ binding domains: a normal-mode analysis.

Authors:  Paolo De Los Rios; Fabio Cecconi; Anna Pretre; Giovanni Dietler; Olivier Michielin; Francesco Piazza; Brice Juanico
Journal:  Biophys J       Date:  2005-04-08       Impact factor: 4.033

Review 3.  The initial steps of myofibril assembly: integrins pave the way.

Authors:  John C Sparrow; Frieder Schöck
Journal:  Nat Rev Mol Cell Biol       Date:  2009-02-04       Impact factor: 94.444

4.  Unusual binding interactions in PDZ domain crystal structures help explain binding mechanisms.

Authors:  Jonathan M Elkins; Carina Gileadi; Leela Shrestha; Claire Phillips; Jing Wang; João R C Muniz; Declan A Doyle
Journal:  Protein Sci       Date:  2010-04       Impact factor: 6.725

5.  Molecular characterization of the Caenorhabditis elegans ALP/Enigma gene alp-1.

Authors:  Caroline R McKeown; Hsiao-Fen Han; Mary C Beckerle
Journal:  Dev Dyn       Date:  2006-02       Impact factor: 3.780

Review 6.  Markesbery disease: autosomal dominant late-onset distal myopathy: from phenotype to ZASP gene identification.

Authors:  Robert C Griggs; Bjarne A Udd
Journal:  Neuromolecular Med       Date:  2010-08-31       Impact factor: 3.843

7.  A class III PDZ binding motif in the myotilin and FATZ families binds enigma family proteins: a common link for Z-disc myopathies.

Authors:  Pernilla von Nandelstadh; Mohamed Ismail; Chiara Gardin; Heli Suila; Ivano Zara; Anna Belgrano; Giorgio Valle; Olli Carpen; Georgine Faulkner
Journal:  Mol Cell Biol       Date:  2008-12-01       Impact factor: 4.272

8.  The ALP-Enigma protein ALP-1 functions in actin filament organization to promote muscle structural integrity in Caenorhabditis elegans.

Authors:  Hsiao-Fen Han; Mary C Beckerle
Journal:  Mol Biol Cell       Date:  2009-03-04       Impact factor: 4.138

9.  [Myofibrillary myopathy due to the ZASP mutation Ala147Thr : two cases with exclusively distal leg involvement].

Authors:  T Kraya; W Kress; D Stoevesant; M Deschauer; S Zierz
Journal:  Nervenarzt       Date:  2013-02       Impact factor: 1.214

Review 10.  ALP/Enigma PDZ-LIM domain proteins in the heart.

Authors:  Ming Zheng; Hongqiang Cheng; Indroneal Banerjee; Ju Chen
Journal:  J Mol Cell Biol       Date:  2009-12-30       Impact factor: 6.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.